Genedant

Genedant is a Singapore-based multi-asset management firm that provides institutional-grade private equity and venture capital investment services to family offices and high-net-worth individuals. The firm delivers customized investment strategies across both private and public markets, focusing primarily on the bio-revolution, advanced manufacturing, and frontier technologies sectors with a specific emphasis on Asian market expansion. Operating through pooled investment structures and fully bespoke portfolios, the firm currently has one active fund in the market to execute its core strategy. Genedant actively deploys capital into early-stage ventures, recently co-leading a $4 million pre-seed financing round for the cancer immunotherapy biotechnology company RyboDyn. The firm's private markets investment team is managed by key personnel including August Lee, Augustine Ooi, Dawn Tay, and Esther Kwan. The investment organization was officially founded in 2020.